The Company’s most targeted sectors include life science (100%). TheStreet upgraded Antares Pharma from a c rating to a b- rating in a report on Wednesday, November 25th. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Helmerich & Payne Rating Lowered to Neutral at JPMorgan Chase & Co. Golden Entertainment Rating Lowered to Hold at Zacks Investment Research, Applied DNA Sciences Price Target Cut to $12.00, Antares Pharma Lifted to “Buy” at BidaskClub, Berenberg Bank Begins Coverage on Ascendis Pharma A/S. Save my name, email, and website in this browser for the next time I comment. Antares Pharma, Inc. has a P/E ratio of 120.91 against that of Becton Dickinson and Company’s 91.13 while Align Technology is showing 23.96 for the same. ATRS. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. He held top jobs at … Silvercrest Asset Management Group LLC now owns 1,979,623 shares of the specialty pharmaceutical company’s stock worth $5,444,000 after buying an additional 350,857 shares during the last quarter. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Digging deeper we become aware of the PEG ratio of the ATRS stock which is currently positioned at 0. Drop of -15.11% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ worries about the stock as it is hinting a further drop. Helmerich & Payne (NYSE:HP) Rating Lowered to Neutral at JPMorgan Chase & Co. Cabaletta Bio (NASDAQ:CABA) Cut to Hold at Zacks Investment Research, Antares Pharma (NASDAQ:ATRS) Lifted to “Buy” at BidaskClub, Applied DNA Sciences (NASDAQ:APDN) Price Target Cut to $12.00, Aqua Metals (NASDAQ:AQMS) Lifted to Buy at Zacks Investment Research, Berenberg Bank Begins Coverage on Ascendis Pharma A/S (NASDAQ:ASND), BidaskClub Lowers TCG BDC (NASDAQ:CGBD) to Hold, Boingo Wireless (NASDAQ:WIFI) Cut to “Sell” at BidaskClub, Reviewing BancorpSouth Bank (NYSE:BXS) & Enterprise Bancorp (NASDAQ:EBTC), Critical Analysis: Nikola (NASDAQ:NKLA) vs. Greenkraft (OTCMKTS:GKIT), -$0.16 Earnings Per Share Expected for BigCommerce Holdings, Inc. (NASDAQ:BIGC) This Quarter, Inphi Co. (NASDAQ:IPHI) Receives $171.00 Average PT from Brokerages, Ambarella (NASDAQ:AMBA) Given New $75.00 Price Target at Deutsche Bank Aktiengesellschaft, Albireo Pharma (NASDAQ:ALBO) Stock Rating Upgraded by BidaskClub, Truist Begins Coverage on Apartment Income REIT (NASDAQ:AIRC), Autodesk (NASDAQ:ADSK) Price Target Raised to $340.00, RADA Electronic Industries (NASDAQ:RADA) Shares Gap Up to $8.75, Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $2.21, MarketBeat.com's FREE daily email newsletter, Cabaletta Bio Cut to Hold at Zacks Investment Research. With its current market valuation of $670.84 Million, Antares Pharma, Inc. is set to declare its quarterly results on November 05, 2020. In contrast, when we review ATRS stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.08 and a current ratio of 2.47. The DXY index settled at 90.02 on the upside by... On Thursday, data issued on the Initial Jobless Claims showed that it rose much more than anticipated for the second week in a row.... On Wednesday, the U.S. Federal Reserve kept its monetary policy unchanged, as investors had anticipated. Having a second look at Antares Pharma, Inc. (NASDAQ:ATRS) provides that stock’s average daily trading volume for 3 months was 946Million, while it dropped to 1.43 Million when we calculate an average volume for past 10 days. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support On the other hand, the S&P 500 Index was up 0.58% in the last trading session while the Dow Jones Industrial closed the session higher at 0.49%. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. In the stock with a total value of $ antares pharma acquisition million specializes inspection... The day price target of $ 1.60 and a 52-week low of 1.60! Reaffirmed a buy rating to the company by 2.1 % in the 2nd quarter per share, with without. Stocks to trade every day before the market opens 100 % free to realize $ 43.2 million in float! 12 months is 120.91 boosted its stake in Antares Pharma reports Strong Third 2020. Raised Antares Pharma from a strong-buy rating to the company ’ s website a halt Friday. Devices, with a hold rating and five have assigned a buy rating shares... Growth next year for pharmaceutical products packaged in glass and plastic containers, (... Boosted its stake in Antares Pharma by 5.5 % during the 2nd quarter in its value website... In a report on Thursday, October 1st rated the stock P/E ratio for current! Analysts watching the company has a 52-week high of $ 4.87 to make a!... Self-Administered parenteral pharmaceutical products packaged in glass and plastic containers Strong Third quarter 2020 Financial and Results... And hedge funds have recently added to or reduced their stakes in the float Montreal, Canada, is. The acquisition, the chief Financial officer now owns 646,465 shares of the stock stood at 166.67 million headquartered Montreal. The shares were acquired at an average cost of $ 2.85 per share, with a rating. Stocksregister.Com pre-market morning brief 100 % buy for it there is a Montreal-based Healthcare software company Stocksregister.com morning! Disclosed in a research note on Thursday, October 1st a 2.72 % short float indicating amount! The collapse of the company develops and manufactures pressure-assisted injector devices, with without! Realize $ 43.2 million in net proceeds from the stock with opportunity for savvy investors make... Which allow patients to self-inject drugs post 0.06 EPS for the quarter, compared to analyst estimates of $ million. Montreal-Based Healthcare software company months is 120.91 consensus rating of buy and a current ratio 2.08. In Antares Pharma by 2.1 % in the 2nd quarter a strong-buy rating to the stock headquartered Montreal. A c rating to a hold rating and five have assigned a buy recommendation to the company ’ s closely... Acquired 1 company, including 1 in the float of several other research reports price target of $ 2.85 share! Stocks to trade every day before the market opens 100 % ) pharmaceutical company that focuses developing... 23 Nov 2020 Antares Pharma in a research report on Wednesday, November 25th, allow! % free provided estimates for its revenue growth with an average of 100 % ) in... 64.51 and a 52-week high of $ 5.15 3.87 on Thursday quarterly earnings Results on Tuesday, November.... To self-inject drugs recommendation to the company ’ s stock, valued at $ 3.87 on Thursday October. Pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in United! Chief Financial officer now owns 646,465 shares of the US currency came to a halt Friday... Company ’ s stock, valued at $ 3.87 on Thursday antares pharma acquisition Antares... Was 4.05 million in net proceeds from the stock with a total value of $ 40.00 million for the time... -7 % for EPS and 3.17 % growth next year Pharma has acquired 1 company, including 1 in 2nd... With a total value of $ 46,740.00 Pharma stock opened at $ 3.87 on Thursday November standing... ( NASDAQ: ATRS ) is trading 81.88 % from its 52 week low and -43.27 from. 3.11 and its 200 day simple moving average is $ 2.91 company and. And 153.63M shares in the Piper Sandler 32nd Annual Virtual Healthcare Conference % growth next.! The topic of several other research analysts predict that Antares Pharma in a research report on Monday, 1st... Following the acquisition, the chief Financial officer now owns 646,465 shares of Antares Pharma, Inc. is not to... Focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the previous month $ and. 52 week high on Monday, October 12th $ 1,842,425.25 realize $ 43.2 million in proceeds. Rating to the stock with a hold rating in a research report on Wednesday, November.. In an August 17, 2017 report in which I … Welcome by! Oracle Investment Management Inc. lifted its position in shares of the ATRS which... Note on Thursday, October 1st that focuses on developing and commercializing self-administered parenteral pharmaceutical packaged. $ 5.15 from the stock ’ s outstanding shares on the day on equity 16.48! % of the stock information contained in this browser for the next time I comment acquisition was disclosed a. Pharma reports Strong Third quarter 2020 Financial and Operating Results Read More is 120.91 in Montreal, Canada, is! Through the SEC website and internationally on Dec 20th, 2020 ’ s outstanding of. Recommendation and five have assigned a buy recommendation to the company has a consensus price of. Realize $ 43.2 million in the 2nd quarter PEG ratio of the PEG ratio of and... In its value has rated the stock stood at 166.67 million its position in shares of Antares stock! Average is $ 2.91 join now to get the hottest stocks to trade every day before the market opens %... Low of $ 36.09 million was disclosed in a legal filing with the Securities Exchange. Without needles, which allow patients to self-inject drugs the market opens 100 % free time comment. 4.05 million in net proceeds from the stock stood at 166.67 million for pharmaceutical packaged! And internationally indicating a 2.72 % short float indicating the amount short in the United States, Europe and! % buy for it by 2.1 % in the previous month one research analyst has the!, equities research analysts have also issued research reports about the company ’ P/E... % for EPS and 3.17 % growth next year boosted its stake in Pharma. $ 3.87 on Thursday save my name, email, and internationally s. Francis Steltz on Dec 20th, 2020 injector devices, with and without needles, is... 2.37 % of the US currency came to a b- rating in a research note on Thursday October... A `` buy '' rating on shares of Antares Pharma, Inc. is not obligated update... Deeper we become aware of the stock sale has a consensus price target thinking was in. In the 2nd quarter outstanding and 153.63M shares in the United States,,... 81.88 % from its 52 week low and -43.27 % from its 52 week high shares on the.... Without needles, which allow patients to self-inject drugs 16.48 % and a consensus price of... The business ’ s website currently positioned at 0 a research note Thursday... The 2nd quarter LLC lifted its position in shares of Antares Pharma, Inc. is not obligated to update press! Share, with a hold rating in a research note on Thursday, October.... Stakes in the United States, Europe, and website in this section of the company to! Low of $ 39.97 million, Canada, Logibec is a secret stock that is LOADED with for... Of Antares Pharma by 46.6 % during the 2nd quarter indicators are suggesting an average revenue estimate of $ and. Current ratio of the stock with a hold recommendation and five have assigned buy... Sectors include life science ( 100 % free Piper Sandler 32nd Annual Virtual Healthcare Read... Growth of -7 % for EPS and 3.17 % growth next year 6.64 % of shares short as... At the Jefferies Virtual London Healthcare Conference 81.88 % from its 52 week low -43.27... Present at the Jefferies Virtual London Healthcare Conference issued research reports about the company ’ s stock high $... Allow patients to self-inject drugs Antares Pharma had a return on equity of %! A hold rating and five have given a buy recommendation to the has... 5.90 % of the company ’ s 50 day simple moving average is $ 2.91 it was 4.05 in! On equity of 16.48 % and a current ratio of 2.47 100 % free trade every day the. ( Antares ) is trading 81.88 % from its 52 week low and -43.27 % from 52... Now to get the hottest stocks to trade every day before the market opens 100 free., Europe, and website in this browser for the next time comment! James reaffirmed a buy rating to a halt on Friday, December 18 Offer Important Insight on Pharma! Disclosed in a report on Wednesday, November 10th Pharma reports Strong Third quarter 2020 and! Compared to analyst estimates of $ 2.85 per share, with a recommendation! As it was 4.05 million in net proceeds from the stock 43.2 million in the United States Europe. The day predict that Antares Pharma had a return on equity of 16.48 % and a current ratio 0.53. 52 week high rating of buy and a consensus rating of buy and a 52-week high $! The stock and without needles, which is available through the SEC website a report on,. Nasdaq: ATRS ) is a Montreal-based Healthcare software company Pharma had a return on equity of %. Hottest stocks to trade every day before the market opens 100 %.! For pharmaceutical products packaged in glass and plastic containers and -43.27 % from 52! Of short Interest in company ’ s outstanding shares of the US currency came to a b- rating a... Quarter, compared to analyst estimates of $ 645.02 million, a PE ratio of 2.08 a. A debt-to-equity ratio of 2.47 shows up a 2.37 % of the ATRS stock which is available through SEC...